- Home
- ARVN vs MATW Comparison
ARVN vs MATW Comparison
Compare ARVN & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | MATW |
|---|---|---|
| Founded | 2015 | 1850 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 755.7M |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ARVN | MATW |
|---|---|---|
| Price | $12.16 | $26.86 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $17.89 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 294.3K |
| Earning Date | 02-10-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 3.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $312,300,000.00 | ★ $1,497,689,000.00 |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | N/A | $0.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $18.50 |
| 52 Week High | $21.00 | $32.00 |
Technical Indicators
Market Signals| Indicator | ARVN | MATW |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 59.28 |
| Support Level | $11.86 | $25.76 |
| Resistance Level | $12.50 | $27.72 |
| Average True Range (ATR) | 0.53 | 0.84 |
| MACD | -0.12 | -0.04 |
| Stochastic Oscillator | 39.41 | 67.45 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MATW Matthews International Corporation
Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.